The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Endocrine Disruption Screening Market Research Report 2025

Global Endocrine Disruption Screening Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1678509

No of Pages : 89

Ask Your Query
Synopsis
Market Analysis and Insights: Global Endocrine Disruption Screening Market
The Endocrine Disruptor Screening is used to screen pesticides, chemicals, and other environmental contaminants for their potential to impact the androgen, estrogen, and thyroid hormone systems.
The global Endocrine Disruption Screening market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, In Vitro Screening accounting for % of the Endocrine Disruption Screening global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Agricultural segment is altered to an % CAGR throughout this forecast period.
China Endocrine Disruption Screening market size is valued at US$ million in 2021, while the North America and Europe Endocrine Disruption Screening are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Endocrine Disruption Screening landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Endocrine Disruption Screening market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Endocrine Disruption Screening market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Endocrine Disruption Screening market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Endocrine Disruption Screening market.
Global Endocrine Disruption Screening Scope and Market Size
Endocrine Disruption Screening market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Endocrine Disruption Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
In Vitro Screening
In Vivo Screening
Segment by Application
Agricultural
Medical
Environmental
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Creative Bioarray
Xenometrix AG
Charles River Laboratories
Eurofins Scientific
Smithers
SGS SA
JRF Global
Mérieux NutriSciences
Alpha Analytical
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruption Screening Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 In Vitro Screening
1.2.3 In Vivo Screening
1.3 Market by Application
1.3.1 Global Endocrine Disruption Screening Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Agricultural
1.3.3 Medical
1.3.4 Environmental
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruption Screening Market Perspective (2017-2028)
2.2 Endocrine Disruption Screening Growth Trends by Region
2.2.1 Endocrine Disruption Screening Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Endocrine Disruption Screening Historic Market Size by Region (2017-2022)
2.2.3 Endocrine Disruption Screening Forecasted Market Size by Region (2023-2028)
2.3 Endocrine Disruption Screening Market Dynamics
2.3.1 Endocrine Disruption Screening Industry Trends
2.3.2 Endocrine Disruption Screening Market Drivers
2.3.3 Endocrine Disruption Screening Market Challenges
2.3.4 Endocrine Disruption Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruption Screening Players by Revenue
3.1.1 Global Top Endocrine Disruption Screening Players by Revenue (2017-2022)
3.1.2 Global Endocrine Disruption Screening Revenue Market Share by Players (2017-2022)
3.2 Global Endocrine Disruption Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocrine Disruption Screening Revenue
3.4 Global Endocrine Disruption Screening Market Concentration Ratio
3.4.1 Global Endocrine Disruption Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruption Screening Revenue in 2021
3.5 Endocrine Disruption Screening Key Players Head office and Area Served
3.6 Key Players Endocrine Disruption Screening Product Solution and Service
3.7 Date of Enter into Endocrine Disruption Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruption Screening Breakdown Data by Type
4.1 Global Endocrine Disruption Screening Historic Market Size by Type (2017-2022)
4.2 Global Endocrine Disruption Screening Forecasted Market Size by Type (2023-2028)
5 Endocrine Disruption Screening Breakdown Data by Application
5.1 Global Endocrine Disruption Screening Historic Market Size by Application (2017-2022)
5.2 Global Endocrine Disruption Screening Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Endocrine Disruption Screening Market Size (2017-2028)
6.2 North America Endocrine Disruption Screening Market Size by Country (2017-2022)
6.3 North America Endocrine Disruption Screening Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Endocrine Disruption Screening Market Size (2017-2028)
7.2 Europe Endocrine Disruption Screening Market Size by Country (2017-2022)
7.3 Europe Endocrine Disruption Screening Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruption Screening Market Size (2017-2028)
8.2 Asia-Pacific Endocrine Disruption Screening Market Size by Country (2017-2022)
8.3 Asia-Pacific Endocrine Disruption Screening Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Endocrine Disruption Screening Market Size (2017-2028)
9.2 Latin America Endocrine Disruption Screening Market Size by Country (2017-2022)
9.3 Latin America Endocrine Disruption Screening Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruption Screening Market Size (2017-2028)
10.2 Middle East & Africa Endocrine Disruption Screening Market Size by Country (2017-2022)
10.3 Middle East & Africa Endocrine Disruption Screening Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Creative Bioarray
11.1.1 Creative Bioarray Company Detail
11.1.2 Creative Bioarray Business Overview
11.1.3 Creative Bioarray Endocrine Disruption Screening Introduction
11.1.4 Creative Bioarray Revenue in Endocrine Disruption Screening Business (2017-2022)
11.1.5 Creative Bioarray Recent Development
11.2 Xenometrix AG
11.2.1 Xenometrix AG Company Detail
11.2.2 Xenometrix AG Business Overview
11.2.3 Xenometrix AG Endocrine Disruption Screening Introduction
11.2.4 Xenometrix AG Revenue in Endocrine Disruption Screening Business (2017-2022)
11.2.5 Xenometrix AG Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Endocrine Disruption Screening Introduction
11.3.4 Charles River Laboratories Revenue in Endocrine Disruption Screening Business (2017-2022)
11.3.5 Charles River Laboratories Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Detail
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Endocrine Disruption Screening Introduction
11.4.4 Eurofins Scientific Revenue in Endocrine Disruption Screening Business (2017-2022)
11.4.5 Eurofins Scientific Recent Development
11.5 Smithers
11.5.1 Smithers Company Detail
11.5.2 Smithers Business Overview
11.5.3 Smithers Endocrine Disruption Screening Introduction
11.5.4 Smithers Revenue in Endocrine Disruption Screening Business (2017-2022)
11.5.5 Smithers Recent Development
11.6 SGS SA
11.6.1 SGS SA Company Detail
11.6.2 SGS SA Business Overview
11.6.3 SGS SA Endocrine Disruption Screening Introduction
11.6.4 SGS SA Revenue in Endocrine Disruption Screening Business (2017-2022)
11.6.5 SGS SA Recent Development
11.7 JRF Global
11.7.1 JRF Global Company Detail
11.7.2 JRF Global Business Overview
11.7.3 JRF Global Endocrine Disruption Screening Introduction
11.7.4 JRF Global Revenue in Endocrine Disruption Screening Business (2017-2022)
11.7.5 JRF Global Recent Development
11.8 Mérieux NutriSciences
11.8.1 Mérieux NutriSciences Company Detail
11.8.2 Mérieux NutriSciences Business Overview
11.8.3 Mérieux NutriSciences Endocrine Disruption Screening Introduction
11.8.4 Mérieux NutriSciences Revenue in Endocrine Disruption Screening Business (2017-2022)
11.8.5 Mérieux NutriSciences Recent Development
11.9 Alpha Analytical
11.9.1 Alpha Analytical Company Detail
11.9.2 Alpha Analytical Business Overview
11.9.3 Alpha Analytical Endocrine Disruption Screening Introduction
11.9.4 Alpha Analytical Revenue in Endocrine Disruption Screening Business (2017-2022)
11.9.5 Alpha Analytical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Endocrine Disruption Screening Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of In Vitro Screening
Table 3. Key Players of In Vivo Screening
Table 4. Global Endocrine Disruption Screening Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Endocrine Disruption Screening Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Endocrine Disruption Screening Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Endocrine Disruption Screening Market Share by Region (2017-2022)
Table 8. Global Endocrine Disruption Screening Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Endocrine Disruption Screening Market Share by Region (2023-2028)
Table 10. Endocrine Disruption Screening Market Trends
Table 11. Endocrine Disruption Screening Market Drivers
Table 12. Endocrine Disruption Screening Market Challenges
Table 13. Endocrine Disruption Screening Market Restraints
Table 14. Global Endocrine Disruption Screening Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Endocrine Disruption Screening Market Share by Players (2017-2022)
Table 16. Global Top Endocrine Disruption Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruption Screening as of 2021)
Table 17. Ranking of Global Top Endocrine Disruption Screening Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Endocrine Disruption Screening Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endocrine Disruption Screening Product Solution and Service
Table 21. Date of Enter into Endocrine Disruption Screening Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Disruption Screening Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Endocrine Disruption Screening Revenue Market Share by Type (2017-2022)
Table 25. Global Endocrine Disruption Screening Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Endocrine Disruption Screening Revenue Market Share by Type (2023-2028)
Table 27. Global Endocrine Disruption Screening Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Endocrine Disruption Screening Revenue Market Share by Application (2017-2022)
Table 29. Global Endocrine Disruption Screening Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Endocrine Disruption Screening Revenue Market Share by Application (2023-2028)
Table 31. North America Endocrine Disruption Screening Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Endocrine Disruption Screening Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Endocrine Disruption Screening Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Endocrine Disruption Screening Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Endocrine Disruption Screening Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Endocrine Disruption Screening Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Endocrine Disruption Screening Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Endocrine Disruption Screening Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Endocrine Disruption Screening Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Endocrine Disruption Screening Market Size by Country (2023-2028) & (US$ Million)
Table 41. Creative Bioarray Company Detail
Table 42. Creative Bioarray Business Overview
Table 43. Creative Bioarray Endocrine Disruption Screening Product
Table 44. Creative Bioarray Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 45. Creative Bioarray Recent Development
Table 46. Xenometrix AG Company Detail
Table 47. Xenometrix AG Business Overview
Table 48. Xenometrix AG Endocrine Disruption Screening Product
Table 49. Xenometrix AG Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 50. Xenometrix AG Recent Development
Table 51. Charles River Laboratories Company Detail
Table 52. Charles River Laboratories Business Overview
Table 53. Charles River Laboratories Endocrine Disruption Screening Product
Table 54. Charles River Laboratories Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 55. Charles River Laboratories Recent Development
Table 56. Eurofins Scientific Company Detail
Table 57. Eurofins Scientific Business Overview
Table 58. Eurofins Scientific Endocrine Disruption Screening Product
Table 59. Eurofins Scientific Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 60. Eurofins Scientific Recent Development
Table 61. Smithers Company Detail
Table 62. Smithers Business Overview
Table 63. Smithers Endocrine Disruption Screening Product
Table 64. Smithers Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 65. Smithers Recent Development
Table 66. SGS SA Company Detail
Table 67. SGS SA Business Overview
Table 68. SGS SA Endocrine Disruption Screening Product
Table 69. SGS SA Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 70. SGS SA Recent Development
Table 71. JRF Global Company Detail
Table 72. JRF Global Business Overview
Table 73. JRF Global Endocrine Disruption Screening Product
Table 74. JRF Global Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 75. JRF Global Recent Development
Table 76. Mérieux NutriSciences Company Detail
Table 77. Mérieux NutriSciences Business Overview
Table 78. Mérieux NutriSciences Endocrine Disruption Screening Product
Table 79. Mérieux NutriSciences Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 80. Mérieux NutriSciences Recent Development
Table 81. Alpha Analytical Company Detail
Table 82. Alpha Analytical Business Overview
Table 83. Alpha Analytical Endocrine Disruption Screening Product
Table 84. Alpha Analytical Revenue in Endocrine Disruption Screening Business (2017-2022) & (US$ Million)
Table 85. Alpha Analytical Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Disruption Screening Market Share by Type: 2021 VS 2028
Figure 2. In Vitro Screening Features
Figure 3. In Vivo Screening Features
Figure 4. Global Endocrine Disruption Screening Market Share by Application in 2021 & 2028
Figure 5. Agricultural Case Studies
Figure 6. Medical Case Studies
Figure 7. Environmental Case Studies
Figure 8. Endocrine Disruption Screening Report Years Considered
Figure 9. Global Endocrine Disruption Screening Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Endocrine Disruption Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Endocrine Disruption Screening Market Share by Region: 2021 VS 2028
Figure 12. Global Endocrine Disruption Screening Market Share by Players in 2021
Figure 13. Global Top Endocrine Disruption Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruption Screening as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Endocrine Disruption Screening Revenue in 2021
Figure 15. North America Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Endocrine Disruption Screening Market Share by Country (2017-2028)
Figure 17. United States Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Endocrine Disruption Screening Market Share by Country (2017-2028)
Figure 21. Germany Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Endocrine Disruption Screening Market Share by Region (2017-2028)
Figure 29. China Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Endocrine Disruption Screening Market Share by Country (2017-2028)
Figure 37. Mexico Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Endocrine Disruption Screening Market Share by Country (2017-2028)
Figure 41. Turkey Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Endocrine Disruption Screening Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Creative Bioarray Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 44. Xenometrix AG Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 45. Charles River Laboratories Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 46. Eurofins Scientific Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 47. Smithers Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 48. SGS SA Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 49. JRF Global Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 50. Mérieux NutriSciences Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 51. Alpha Analytical Revenue Growth Rate in Endocrine Disruption Screening Business (2017-2022)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock